“…However, despite such great success, lithium has a narrow therapeutic index, with therapeutic serum levels between 0.6 and 1.5 mEq/L 3,4 . In the initial phase of treatment, excessive thirst, nausea, diarrhea, epigastric pain, muscle weakness and fatigue are symptoms that cause great discomfort to patients, often leading to low adherence to medication 3 . The most common neurologic symptom is tremor, affecting 25-50% of users.…”